nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Talipes—Riluzole—amyotrophic lateral sclerosis	0.0952	0.161	CcSEcCtD
Vigabatrin—Muscle spasticity—Riluzole—amyotrophic lateral sclerosis	0.0424	0.0716	CcSEcCtD
Vigabatrin—GABBR1—Activation of G protein gated Potassium channels—KCNJ10—amyotrophic lateral sclerosis	0.0193	0.0734	CbGpPWpGaD
Vigabatrin—ABAT—GABA synthesis, release, reuptake and degradation—SLC6A1—amyotrophic lateral sclerosis	0.0191	0.0727	CbGpPWpGaD
Vigabatrin—SLC36A1—hindbrain—amyotrophic lateral sclerosis	0.0187	0.13	CbGeAlD
Vigabatrin—ABAT—hindbrain—amyotrophic lateral sclerosis	0.0186	0.129	CbGeAlD
Vigabatrin—Stridor—Riluzole—amyotrophic lateral sclerosis	0.0176	0.0297	CcSEcCtD
Vigabatrin—GABBR1—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.0163	0.0618	CbGpPWpGaD
Vigabatrin—GABBR1—Activation of GABAB receptors—KCNJ10—amyotrophic lateral sclerosis	0.0138	0.0525	CbGpPWpGaD
Vigabatrin—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0228	CcSEcCtD
Vigabatrin—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0224	CcSEcCtD
Vigabatrin—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0195	CcSEcCtD
Vigabatrin—ABAT—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.0114	0.0432	CbGpPWpGaD
Vigabatrin—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.011	0.0418	CbGpPWpGaD
Vigabatrin—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0184	CcSEcCtD
Vigabatrin—SLC36A1—brainstem—amyotrophic lateral sclerosis	0.0107	0.0745	CbGeAlD
Vigabatrin—ABAT—brainstem—amyotrophic lateral sclerosis	0.0107	0.074	CbGeAlD
Vigabatrin—GABBR1—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.0106	0.0403	CbGpPWpGaD
Vigabatrin—ABAT—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.0101	0.0385	CbGpPWpGaD
Vigabatrin—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0171	CcSEcCtD
Vigabatrin—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00954	0.0161	CcSEcCtD
Vigabatrin—GABBR1—medulla oblongata—amyotrophic lateral sclerosis	0.00953	0.0661	CbGeAlD
Vigabatrin—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00935	0.0355	CbGpPWpGaD
Vigabatrin—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00885	0.0149	CcSEcCtD
Vigabatrin—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00876	0.0148	CcSEcCtD
Vigabatrin—GABBR1—spinal cord—amyotrophic lateral sclerosis	0.0085	0.0589	CbGeAlD
Vigabatrin—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00842	0.0142	CcSEcCtD
Vigabatrin—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00803	0.0136	CcSEcCtD
Vigabatrin—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00796	0.0134	CcSEcCtD
Vigabatrin—Mania—Riluzole—amyotrophic lateral sclerosis	0.00789	0.0133	CcSEcCtD
Vigabatrin—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00769	0.013	CcSEcCtD
Vigabatrin—ABAT—medulla oblongata—amyotrophic lateral sclerosis	0.00744	0.0516	CbGeAlD
Vigabatrin—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00692	0.0117	CcSEcCtD
Vigabatrin—GABBR1—cerebellum—amyotrophic lateral sclerosis	0.00674	0.0467	CbGeAlD
Vigabatrin—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00667	0.0113	CcSEcCtD
Vigabatrin—ABAT—spinal cord—amyotrophic lateral sclerosis	0.00664	0.046	CbGeAlD
Vigabatrin—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00647	0.0246	CbGpPWpGaD
Vigabatrin—GABBR1—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.00643	0.0244	CbGpPWpGaD
Vigabatrin—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00631	0.0106	CcSEcCtD
Vigabatrin—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00627	0.0106	CcSEcCtD
Vigabatrin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00607	0.0102	CcSEcCtD
Vigabatrin—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00992	CcSEcCtD
Vigabatrin—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00986	CcSEcCtD
Vigabatrin—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00986	CcSEcCtD
Vigabatrin—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00574	0.00968	CcSEcCtD
Vigabatrin—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00567	0.00957	CcSEcCtD
Vigabatrin—SLC36A1—nervous system—amyotrophic lateral sclerosis	0.00563	0.039	CbGeAlD
Vigabatrin—ABAT—nervous system—amyotrophic lateral sclerosis	0.00559	0.0388	CbGeAlD
Vigabatrin—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00554	0.00935	CcSEcCtD
Vigabatrin—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00551	0.0209	CbGpPWpGaD
Vigabatrin—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00925	CcSEcCtD
Vigabatrin—GABBR1—brain—amyotrophic lateral sclerosis	0.00548	0.038	CbGeAlD
Vigabatrin—SLC36A1—central nervous system—amyotrophic lateral sclerosis	0.00542	0.0376	CbGeAlD
Vigabatrin—ABAT—central nervous system—amyotrophic lateral sclerosis	0.00538	0.0373	CbGeAlD
Vigabatrin—SLC36A1—cerebellum—amyotrophic lateral sclerosis	0.0053	0.0367	CbGeAlD
Vigabatrin—ABAT—cerebellum—amyotrophic lateral sclerosis	0.00526	0.0365	CbGeAlD
Vigabatrin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00849	CcSEcCtD
Vigabatrin—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00498	0.0084	CcSEcCtD
Vigabatrin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00824	CcSEcCtD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00487	0.0185	CbGpPWpGaD
Vigabatrin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00786	CcSEcCtD
Vigabatrin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00786	CcSEcCtD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0045	0.0171	CbGpPWpGaD
Vigabatrin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00748	CcSEcCtD
Vigabatrin—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00748	CcSEcCtD
Vigabatrin—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00739	CcSEcCtD
Vigabatrin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00729	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00431	0.0164	CbGpPWpGaD
Vigabatrin—SLC36A1—brain—amyotrophic lateral sclerosis	0.0043	0.0298	CbGeAlD
Vigabatrin—ABAT—brain—amyotrophic lateral sclerosis	0.00427	0.0296	CbGeAlD
Vigabatrin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00703	CcSEcCtD
Vigabatrin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00703	CcSEcCtD
Vigabatrin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00703	CcSEcCtD
Vigabatrin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00692	CcSEcCtD
Vigabatrin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00687	CcSEcCtD
Vigabatrin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00402	0.00679	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00398	0.0151	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00397	0.0151	CbGpPWpGaD
Vigabatrin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00666	CcSEcCtD
Vigabatrin—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00661	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00384	0.0146	CbGpPWpGaD
Vigabatrin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00635	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00366	0.0139	CbGpPWpGaD
Vigabatrin—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00612	CcSEcCtD
Vigabatrin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00608	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00351	0.0133	CbGpPWpGaD
Vigabatrin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00584	CcSEcCtD
Vigabatrin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00582	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00338	0.0128	CbGpPWpGaD
Vigabatrin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0056	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0033	0.0125	CbGpPWpGaD
Vigabatrin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00553	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00326	0.0124	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00326	0.0124	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00326	0.0124	CbGpPWpGaD
Vigabatrin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00545	CcSEcCtD
Vigabatrin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00542	CcSEcCtD
Vigabatrin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00542	CcSEcCtD
Vigabatrin—Depression—Riluzole—amyotrophic lateral sclerosis	0.0032	0.0054	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00531	CcSEcCtD
Vigabatrin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00527	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00305	0.0116	CbGpPWpGaD
Vigabatrin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00512	CcSEcCtD
Vigabatrin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00508	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00299	0.0113	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00294	0.0112	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00291	0.0111	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00289	0.011	CbGpPWpGaD
Vigabatrin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00484	CcSEcCtD
Vigabatrin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00484	CcSEcCtD
Vigabatrin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00479	CcSEcCtD
Vigabatrin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00478	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00281	0.0107	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00278	0.0105	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00278	0.0105	CbGpPWpGaD
Vigabatrin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00272	0.0046	CcSEcCtD
Vigabatrin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00454	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00269	0.0102	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00259	0.00984	CbGpPWpGaD
Vigabatrin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00426	CcSEcCtD
Vigabatrin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00423	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0025	0.0095	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0025	0.0095	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0025	0.0095	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00247	0.0094	CbGpPWpGaD
Vigabatrin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00415	CcSEcCtD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00246	0.00935	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00244	0.00927	CbGpPWpGaD
Vigabatrin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00411	CcSEcCtD
Vigabatrin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00409	CcSEcCtD
Vigabatrin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00407	CcSEcCtD
Vigabatrin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00397	CcSEcCtD
Vigabatrin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00393	CcSEcCtD
Vigabatrin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00391	CcSEcCtD
Vigabatrin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00389	CcSEcCtD
Vigabatrin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00387	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00229	0.00869	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00228	0.00867	CbGpPWpGaD
Vigabatrin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00382	CcSEcCtD
Vigabatrin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00225	0.0038	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00223	0.00847	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00219	0.00833	CbGpPWpGaD
Vigabatrin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00369	CcSEcCtD
Vigabatrin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00367	CcSEcCtD
Vigabatrin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00214	0.0036	CcSEcCtD
Vigabatrin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00214	0.0036	CcSEcCtD
Vigabatrin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00214	0.0036	CcSEcCtD
Vigabatrin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00359	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00213	0.00808	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00213	0.00808	CbGpPWpGaD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00358	CcSEcCtD
Vigabatrin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00356	CcSEcCtD
Vigabatrin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00348	CcSEcCtD
Vigabatrin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00345	CcSEcCtD
Vigabatrin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00343	CcSEcCtD
Vigabatrin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00339	CcSEcCtD
Vigabatrin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00336	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0019	0.0072	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00315	CcSEcCtD
Vigabatrin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00312	CcSEcCtD
Vigabatrin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0031	CcSEcCtD
Vigabatrin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00307	CcSEcCtD
Vigabatrin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00304	CcSEcCtD
Vigabatrin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00178	0.003	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00298	CcSEcCtD
Vigabatrin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00298	CcSEcCtD
Vigabatrin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00295	CcSEcCtD
Vigabatrin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00295	CcSEcCtD
Vigabatrin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00285	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00283	CcSEcCtD
Vigabatrin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00274	CcSEcCtD
Vigabatrin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00273	CcSEcCtD
Vigabatrin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00273	CcSEcCtD
Vigabatrin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00255	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00148	0.00561	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00147	0.00559	CbGpPWpGaD
Vigabatrin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00248	CcSEcCtD
Vigabatrin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00244	CcSEcCtD
Vigabatrin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00236	CcSEcCtD
Vigabatrin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00228	CcSEcCtD
Vigabatrin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0022	CcSEcCtD
Vigabatrin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00218	CcSEcCtD
Vigabatrin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00218	CcSEcCtD
Vigabatrin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00216	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00125	0.00475	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00125	0.00475	CbGpPWpGaD
Vigabatrin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00205	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00111	0.00423	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00106	0.00405	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000835	0.00317	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000758	0.00288	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000645	0.00245	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000591	0.00224	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000556	0.00211	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000527	0.002	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00051	0.00194	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000453	0.00172	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000448	0.0017	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000374	0.00142	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000364	0.00138	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000331	0.00126	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000308	0.00117	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000289	0.0011	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000275	0.00104	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000235	0.000894	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000221	0.00084	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000195	0.000743	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000182	0.000691	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.00015	0.000571	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000116	0.00044	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000109	0.000416	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.82e-05	0.000373	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.42e-05	0.000282	CbGpPWpGaD
